Neuraxis, Inc. (NRXS) Stock Price

NRXSStock

$6.04+145.75%52W

Market Cap$75.85M

P/E—

PEG Ratio—

Div yield—

Beta1.50

NRXS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)2.00%

Price vs S&P 500 (4W)-10.10%

VGM Score49.84

Book Value / Share (Quarterly)$0.50

P/TBV (Annual)15.48x

Revenue Growth (3Y)10.02%

Cash Flow / Share (Quarterly)$-0.54

Price vs S&P 500 (YTD)21.74%

Gross Margin (TTM)85.00%

Net Profit Margin (TTM)-170.11%

EPS (TTM)$-0.73

10-Day Avg Trading Volume0.11M

EPS Excl Extra (TTM)$-0.73

Revenue Growth (5Y)13.08%

EPS (Annual)$-0.86

ROI (Annual)-219.88%

Gross Margin (Annual)84.23%

Net Profit Margin (5Y Avg)-281.94%

Cash / Share (Quarterly)$0.62

Revenue Growth QoQ (YoY)79.52%

ROA (Last FY)-121.81%

Revenue Growth TTM (YoY)45.88%

EBITD / Share (TTM)$-0.72

Operating Margin (TTM)-169.93%

Cash Flow / Share (Annual)$-0.62

P/B Ratio13.72x

P/B Ratio (Quarterly)14.40x

Net Income / Employee (Annual)$-325,000

EV / Revenue (TTM)16.79x

Net Interest Coverage (TTM)-73.85x

ROA (TTM)-103.99%

EPS Incl Extra (Annual)$-0.86

Current Ratio (Annual)2.05x

Quick Ratio (Quarterly)2.65x

3-Month Avg Trading Volume0.13M

52-Week Price Return145.75%

Revenue / Employee (TTM)$178,400

Tangible BV / Share (Quarterly)$0.48

P/S Ratio (Annual)22.09x

Asset Turnover (Annual)0.56x

52-Week High$9.33

Operating Margin (5Y Avg)-228.01%

EPS Excl Extra (Annual)$-0.86

CapEx CAGR (5Y)34.32%

26-Week Price Return13.25%

Quick Ratio (Annual)1.85x

13-Week Price Return-18.30%

Total Debt / Equity (Annual)0.04x

Current Ratio (Quarterly)2.89x

Enterprise Value$71.88M

Revenue / Share Growth (5Y)4.46%

Asset Turnover (TTM)0.61x

Revenue / Employee (Annual)$148,700

Inventory Turnover (Annual)3.73x

Pretax Margin (Annual)-218.55%

Cash / Share (Annual)$0.47

3-Month Return Std Dev48.56%

Gross Margin (5Y Avg)86.06%

Net Income / Employee (TTM)$-303,500

ROE (Last FY)-229.47%

Net Interest Coverage (Annual)-55.83x

EPS Basic Excl Extra (Annual)$-0.86

Receivables Turnover (TTM)13.62x

Total Debt / Equity (Quarterly)0.02x

EPS Incl Extra (TTM)$-0.73

Receivables Turnover (Annual)16.21x

ROI (TTM)-179.27%

P/S Ratio (TTM)18.42x

Pretax Margin (5Y Avg)-281.94%

Revenue / Share (Annual)$0.39

Tangible BV / Share (Annual)$0.29

Price vs S&P 500 (52W)127.44%

Year-to-Date Return33.70%

5-Day Price Return-3.04%

EPS Normalized (Annual)$-0.86

ROA (5Y Avg)-777.50%

Net Profit Margin (Annual)-218.55%

Month-to-Date Return-2.88%

Cash Flow / Share (TTM)$-2.00

EBITD / Share (Annual)$-0.86

Operating Margin (Annual)-219.37%

LT Debt / Equity (Annual)0.00x

EPS Basic Excl Extra (TTM)$-0.73

P/TBV (Quarterly)15.10x

P/B Ratio (Annual)14.23x

Inventory Turnover (TTM)4.66x

Pretax Margin (TTM)-170.11%

Book Value / Share (Annual)$0.32

Price vs S&P 500 (13W)-21.10%

Beta1.50x

Revenue / Share (TTM)$0.39

ROE (TTM)-185.74%

52-Week Low$2.21

vGradeF

gGradeB

mGradeC

vgmGradeC

NRXS Earnings Surprise History

Q2 25-0.22est. -0.19

Q3 25-0.24est. -0.20

Q4 25-0.10est. -0.21

Q2 26-0.19est. -0.32

NRXS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	Price
NRXSNeuraxis, Inc.	F	B	C	$6.04
MDTMedtronic plc	B	C	C	$91.14
LIVNLivaNova PLC Ordinary Shares	C	B	B	$79.41
ITGRInteger Holdings Corporation	C	C	B	$125.39
TMDXTransMedics Group, Inc. Common Stock	C	B	C	$93.60
AXGNAxogen, Inc. Common Stock	F	B	B	$49.93
BLFSBioLife Solutions Inc.	D	C	A	$37.22
CNMDCONMED Corporation	B	C	B	$51.13
CBLLCeriBell, Inc. Common Stock	D	A	B	$23.95
INMDInMode Ltd. Ordinary Shares	A	D	C	$15.03
ELMDElectromed, Inc.	D	B	B	$39.34
CVCapsoVision, Inc. Common Stock	F	D	C	$5.85
STEXStreamex Corp. Common Stock	—	C	F	$0.76
FOCLEDAP TMS S.A. American Depositary Shares	C	B	C	$4.39
STXSStereotaxis, Inc. Common Stock	D	D	D	$1.41
VANIVivani Medical, Inc. Common Stock (DE)	—	—	C	$1.42
HYPRHyperfine, Inc. Class A Common Stock	C	A	D	$0.87
ECORelectroCore, Inc. Common Stock	C	A	B	$9.47
OMOutset Medical, Inc. Common Stock	A	C	D	$4.30
POCIPrecision Optics Corporation, Inc. Common Stock	C	A	C	$4.41
QTIQT Imaging Holdings, Inc. Common Stock	D	A	D	$3.24
IRIXIridex Corp	B	D	D	$0.72
NDRAENDRA Life Sciences Inc. Common Stock	D	—	C	$4.75
NXLNexalin Technology, Inc. Common Stock	D	C	D	$0.32
ITOCiTonic Holdings Ltd Class A Ordinary Shares	—	A	C	$0.27
NUWENuwellis, Inc. Common Stock	A	D	F	$0.96
EDAPEDAP TMS SA	C	B	C	$4.18
EYESCorgi Data & Surveillance ETF	—	C	C	$29.06
FONRFonar Corporation	B	D	C	$0.00
MASIMasimo Corporation	D	D	C	$0.00
QSIAWQuantum-Si Incorporated Warrant	—	—	F	$0.00
TIVCTivic Health Systems, Inc. Common Stock	—	B	F	$0.17

About Neuraxis, Inc.

Neuraxis Inc is a growth-stage company developing neuromodulation therapies for chronic and debilitating conditions in children and adolescents. The company's proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology targets disorders of gut-brain interaction (DGBIs) in the pediatric population.